Live Breaking News & Updates on Longboard Pharmaceuticals Trading Down

Stay updated with breaking news from Longboard pharmaceuticals trading down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cantor Fitzgerald Reaffirms "Overweight" Rating for Longboard Pharmaceuticals (NASDAQ:LBPH)

Cantor Fitzgerald Reaffirms "Overweight" Rating for Longboard Pharmaceuticals (NASDAQ:LBPH)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Robertw Baird , Td Asset Management Inc , Analyst Recommendations For Longboard Pharmaceuticals , Bourgeon Capital Management , Longboard Pharmaceuticals , Jennison Associates , Hedge Funds Weigh In On Longboard Pharmaceuticals , Asset Management Inc , Cantor Fitzgerald , News Ratings For Longboard Pharmaceuticals Daily , Longboard Pharmaceuticals Trading Down , Longboard Pharmaceuticals Inc , Polar Capital Holdings Plc , Free Report , Pharmaceuticals Trading Down , Get Free Report , Management Inc , Capital Management , Capital Holdings Plc , Longboard Pharmaceuticals Daily ,

Longboard Pharmaceuticals (NASDAQ:LBPH) Shares Gap Up to $21.30

Longboard Pharmaceuticals (NASDAQ:LBPH) Shares Gap Up to $21.30
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Robertw Baird , News Ratings For Longboard Pharmaceuticals Daily , Longboard Pharmaceuticals Company Profile , Asset Management Inc , Jennison Associates , Longboard Pharmaceuticals Inc , Longboard Pharmaceuticals , Polar Capital Holdings Plc , Platinum Investment Management Ltd , Cantor Fitzgerald , Parkman Healthcare Partners , Longboard Pharmaceuticals Trading Down , Get Free Report , Pharmaceuticals Trading Down , Capital Holdings Plc , Healthcare Partners , Management Inc , Platinum Investment Management , Longboard Pharmaceuticals Daily ,

Longboard Pharmaceuticals (NASDAQ:LBPH) Earns "Overweight" Rating from Cantor Fitzgerald

Longboard Pharmaceuticals (NASDAQ:LBPH) Earns "Overweight" Rating from Cantor Fitzgerald
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Insider Transactions At Longboard Pharmaceuticals , Manufacturers Life Insurance Company , Arena Pharmaceuticals Inc , Institutional Trading Of Longboard Pharmaceuticals , Analyst Recommendations For Longboard Pharmaceuticals , Longboard Pharmaceuticals Company Profile , Longboard Pharmaceuticals , Longboard Pharmaceuticals Trading Down , Nuveen Asset Management , Citigroup Inc , News Ratings For Longboard Pharmaceuticals Daily , Longboard Pharmaceuticals Inc , Cantor Fitzgerald , Northern Trust Corp , Goldman Sachs Group Inc , Securities Exchange Commission , Free Report , Pharmaceuticals Trading Down , Get Free Report , Exchange Commission , Asset Management , Sachs Group , Trust Corp , Longboard Pharmaceuticals Daily ,

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Short Interest Up 165.2% in June

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) was the target of a large increase in short interest in the month of June. As of June 30th, there was short interest totalling 732,800 shares, an increase of 165.2% from the June 15th total of 276,300 shares. Currently, 5.2% of the company’s shares are short sold. […] ....

News Ratings For Longboard Pharmaceuticals Daily , Bourgeon Capital Management , Asset Management Inc , Longboard Pharmaceuticals Inc , Longboard Pharmaceuticals Trading Down , Hedge Funds Weigh In On Longboard Pharmaceuticals , Longboard Pharmaceuticals , Health Asset Management , Longboard Pharmaceuticals Company Profile , Cantor Fitzgerald , Blackrock Inc , Get Free Report , Pharmaceuticals Trading Down , Capital Management , Management Inc , Prosight Management , Longboard Pharmaceuticals Daily ,

B. Riley Comments on Longboard Pharmaceuticals, Inc.'s Q2 2023 Earnings (NASDAQ:LBPH)

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Rating) – Research analysts at B. Riley issued their Q2 2023 earnings per share (EPS) estimates for Longboard Pharmaceuticals in a report issued on Wednesday, May 10th. B. Riley analyst K. Patel anticipates that the company will post earnings per share of ($0.55) for the quarter. B. Riley currently […] ....

Institutional Trading Of Longboard Pharmaceuticals , Bourgeon Capital Management , Health Asset Management , Longboard Pharmaceuticals Trading Down , Cantor Fitzgerald , Longboard Pharmaceuticals Company Profile , Blackrock Inc , News Ratings For Longboard Pharmaceuticals Daily , Longboard Pharmaceuticals , Longboard Pharmaceuticals Inc , Get Rating , Longboard Pharmaceutical , Pharmaceuticals Trading Down , Capital Management , Longboard Pharmaceuticals Daily , Nasdaq Lbph , Earnings Estimates , B Riley ,